financetom
Business
financetom
/
Business
/
Alphabet Insider Sold Shares Worth $3,347,580, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alphabet Insider Sold Shares Worth $3,347,580, According to a Recent SEC Filing
Mar 21, 2024 6:52 AM

09:15 AM EDT, 03/21/2024 (MT Newswires) -- Sundar Pichai, Director, Chief Executive Officer, on March 20, 2024, sold 22,500 shares in Alphabet (GOOG) for $3,347,580. Following the Form 4 filing with the SEC, Pichai has control over a total of 3,132,800 shares of the company, with 3,132,800 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1652044/000120919124005015/xslF345X03/doc4.xml

Price: 150.43, Change: +0.75, Percent Change: +0.5

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
APA curtails US natgas and NGL production in second quarter on weak prices
APA curtails US natgas and NGL production in second quarter on weak prices
Jul 9, 2025
July 9 (Reuters) - Oil and gas firm APA Corp ( APA ) said on Wednesday it curtailed about 10 million of cubic feet per day (MMcfpd) of U.S. natural gas production and 750 barrels per day of U.S. natural gas liquids production in the second quarter in response to weak prices. ...
Uipath Insider Sold Shares Worth $592,668, According to a Recent SEC Filing
Uipath Insider Sold Shares Worth $592,668, According to a Recent SEC Filing
Jul 9, 2025
04:37 PM EDT, 07/09/2025 (MT Newswires) -- Daniel Dines, 10% Owner, Director, CEO and Chairman, on July 09, 2025, sold 45,000 shares in Uipath ( PATH ) for $592,668. Following the Form 4 filing with the SEC, Dines has control over a total of 30,441,961 Class A common shares of the company, with 24,918,585 shares held directly and 5,523,376 controlled...
Inventiva Names Jason Campagna Chief Medical Officer
Inventiva Names Jason Campagna Chief Medical Officer
Jul 9, 2025
04:36 PM EDT, 07/09/2025 (MT Newswires) -- Inventiva ( IVA ) said late Wednesday it appointed Jason Campagna as chief medical officer and president of research and development. Campagna succeeds Michael Cooreman, who is departing as chief medical officer. Co-founder and Chief Scientific Officer Pierre Broqua will transition to a consulting role as scientific advisor. Campagna most recently was the...
Rhythm Pharmaceuticals to Offer $150 Million in Common Stock
Rhythm Pharmaceuticals to Offer $150 Million in Common Stock
Jul 9, 2025
04:37 PM EDT, 07/09/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said late Wednesday it plans to offer $150 million of common stock. The company also plans to offer the underwriters a 30-day option to buy up to $22.5 million of additional shares. Shares of the company were down 1.7% in recent after-hours activity. Price: 87.50, Change: -1.50, Percent...
Copyright 2023-2025 - www.financetom.com All Rights Reserved